510(k) K190882

XenoSure Biologic Patch by Lemaitre Vascular — Product Code PSQ

K190882 is an FDA 510(k) premarket notification submitted by Lemaitre Vascular for the device "XenoSure Biologic Patch". The FDA issued a decision of Substantially Equivalent on February 13, 2020. The device falls under product code PSQ (Intracardiac Patch Or Pledget, Biologically Derived), a Class II device regulated under 21 CFR 870.3470. Lemaitre Vascular has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 13, 2020
Date Received
April 4, 2019
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Intracardiac Patch Or Pledget, Biologically Derived
Device Class
Class II
Regulation Number
870.3470
Review Panel
CV
Submission Type

To repair defects, to be used for patch grafting, to repair tissue, and to buttress sutures in the heart and vasculature.